1. Home
  2. INDP vs LMFA Comparison

INDP vs LMFA Comparison

Compare INDP & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$2.36

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.25

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
LMFA
Founded
2000
2008
Country
United States
United States
Employees
N/A
19
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.6M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
INDP
LMFA
Price
$2.36
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
67.6K
298.4K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.66
EPS
N/A
N/A
Revenue
N/A
$8,844,733.00
Revenue This Year
N/A
$4.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.18
52 Week High
$13.24
$5.14

Technical Indicators

Market Signals
Indicator
INDP
LMFA
Relative Strength Index (RSI) 45.22 42.62
Support Level $2.36 $0.18
Resistance Level $3.11 $0.32
Average True Range (ATR) 0.41 0.03
MACD -0.07 -0.00
Stochastic Oscillator 25.71 27.69

Price Performance

Historical Comparison
INDP
LMFA

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: